573675-31-7

Usage

Uses

Used in Pharmaceutical Industry:
7-bromo-4-chloropyrido[3,2-d]pyrimidine is used as an intermediate in the synthesis of pharmaceuticals for its potential role in the development of new drugs. Its unique chemical structure allows it to be a valuable component in the creation of various medicinal compounds, contributing to advancements in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 7-bromo-4-chloropyrido[3,2-d]pyrimidine serves as an intermediate in the synthesis of agrochemicals, playing a crucial role in the development of new pesticides, herbicides, and other agricultural chemicals. Its incorporation into these products can enhance their effectiveness and contribute to more sustainable agricultural practices.
Used in Research and Development:
7-bromo-4-chloropyrido[3,2-d]pyrimidine is also utilized in research and development within the chemical and pharmaceutical industries. Its unique properties make it a promising candidate for exploration in various scientific studies, potentially leading to new discoveries and innovations in these fields.

InChI:InChI=1/C7H3BrClN3/c8-4-1-5-6(10-2-4)7(9)12-3-11-5/h1-3H

Upstream product

• 669066-89-1 3-amino-5-bromopyridine-2-carboxylic acid amide 
• 573675-25-9 5-bromo-3-nitropyridine-2-carbonitrile 
• 573675-29-3 7-bromopyrido[3,2-d]pyrimidin-4-ol 

Relevant academic research and scientific papers

ION CHANNEL INHIBITOR COMPOUNDS FOR CANCER TREATMENT

The present invention concerns a compound of following general formula (I): where: either R is an R1 group and R′ is an -A1-Cy1 group, or R is an -A1-Cy1 group and R′ is an R1 group, R1 particularly being H or (C1-C6)alkyl group;A1 being an —NH— radical or —NH—CH2— radical;Cy1 particularly being a phenyl group,A is a fused (hetero)aromatic ring having 5 to 7 atoms, for use for treating cancer.

BRIDGED BICYCLIC AMINO THIAZINE DIOXIDE COMPOUNDS AS INHIBITORS OF BETA-SECRETASE AND METHODS OF USE THEREOF

The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula I: wherein variables A4, A5, A6, A8, R1, R2, R3, R7 and n of Formula I, independently, are defined herein. The invention also provides pharmaceutical compositions comprising the compounds, and corresponding uses of the compounds and compositions for treatment of disorders and/or conditions related to A-beta plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer's Disease, cognitive deficits, cognitive impairments, schizophrenia and other central nervous system conditions. The invention further provides compounds of Formula II and sub-formula embodiments thereof, compounds of Formula III, intermediates and processes and methods useful for the preparation of compounds of Formulas I-III, and sub-Formulas thereof.

CAPSAICIN RECEPTOR AGONISTS

Capsaicin receptor agonists are provided. Such compounds are ligands that may be used to modulate VRl activity in vivo or in vitro, and are particularly useful in the treatment of conditions responsive to capsaicin receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.